Company Quick10K Filing
Nate's Food
10-K 2018-05-31 Filed 2019-04-19
10-Q 2018-02-28 Filed 2018-07-06
10-Q 2017-11-30 Filed 2018-05-24
10-Q 2017-08-31 Filed 2018-02-21
10-K 2017-05-31 Filed 2017-12-22
10-Q 2017-02-28 Filed 2017-05-17
10-Q 2016-11-30 Filed 2017-01-23
10-Q 2016-08-31 Filed 2016-10-24
10-K 2016-05-31 Filed 2016-10-06
10-Q 2016-02-29 Filed 2016-06-28
10-Q 2015-11-30 Filed 2016-01-21
10-Q 2015-08-31 Filed 2015-10-20
10-K 2015-05-31 Filed 2015-09-21
10-Q 2015-02-28 Filed 2015-04-14
10-Q 2014-11-30 Filed 2015-01-20
10-Q 2014-08-31 Filed 2014-11-10
10-Q 2010-09-30 Filed 2010-11-18
10-K 2010-06-30 Filed 2010-10-13
10-Q 2010-03-31 Filed 2010-05-14
10-Q 2009-12-31 Filed 2010-02-11
8-K 2018-01-08
8-K 2017-12-21
8-K 2017-12-21

Nate's Food Financials

NHMD Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Natcore Technology (NXT)
Nutra Pharma (NPHC) 0 71% -0.2 -2,939% 252 5,614 106 75 -7,398 -6,591 1,498
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Nate's Food (NHMD) 0 92% -0.1 -6,857% 7 825 3 3 -481 -455 30
Amplitude Healthcare (AMHCU)
Galileo Acquisition (GLEO)
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
New You (NWYU)
VNUE (VNUE) 0 0% -2.0 -621% 168 3,666 200 0 -1,042 -634 1,242
Electromedical Technologies (ELCQ)
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
XsunX (XSNX) 0 47% 0.1 1,089% 215 2,451 1,609 753 2,344 2,417 194
Pacific Ventures (PACV) 0 25% -3.8 -65% 1,799 5,073 3,514 883 -1,171 -615 2,318
Anchiano Therapeutics (ANCN)
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30

Balance Sheet ($'000)2014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-31
Cash24010184731229312017
Accounts Receivable
Inventory5
PP&E3743953953853753660
Assets24018521947844341338740536912017
Accounts Payable33
Long-Term Debt102420020020018715436237373737
Liabilities771241744166151,0291,2582,851733868765526613641709825
Stockholders' Equity-74-84-172-331-396-551-815-2,438-345-464-397-525-612-641-708-818
Income Statement ($'000)2014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-31
Revenue112218003810211
Cost of Revenue00013507050-0000
Gross Profit112830-73310211
R&D67142402-2200020000
SG&A458536029677318920397396198442115
Tax000000000
Net Income-71-5991,780-2,291-125-329-709-1,7651,5111,80917-599-293-29-159
Cash Flow ($'000)2014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-31
Cash Operating-3-5-38-26-11-53-36-22-144-45-26-31-2-6
Cash Investing-99-12-2100000000
Cash Financing543-011012813201457200017